NEW YORK, April 20, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Zymeworks Inc. (“Zymeworks” or the “Company”) (NASDAQ: ZYME). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980 The investigation concerns whether Zymeworks and certain of its officers and/or directors have engaged in securities
NEW YORK, March 27, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Spruce Biosciences, Inc. (“Spruce” or the “Company”) (NASDAQ: SPRB). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Spruce and certain of its officers and/or directors have engaged in securities
NEW YORK, March 25, 2024 /PRNewswire/ — Pomerantz LLP is investigating whether the Board of Directors of Sotera Health Company (NASDAQ: SHC) (“Sotera”) potentially breached their fiduciary duties to shareholders. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. This investigation concerns possible corporate misconduct related to the disposal of waste substances
NEW YORK, March 19, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Super Micro Computer, Inc. (“Super Micro” or the “Company”) (NASDAQ: SMCI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Super Micro and certain of its officers and/or directors have engaged in securities
NEW YORK, March 19, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Sonder Holdings Inc. (“Sonder” or the “Company”) (NASDAQ: SOND). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Sonder and certain of its officers and/or directors have engaged in securities fraud or other
NEW YORK, March 11, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Catalent, Inc. (“Catalent” or the “Company”) (NYSE: CTLT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Catalent and certain of its officers and/or directors have engaged in securities fraud or other
NEW YORK, March 11, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Daqo New Energy Corp. (“Daqo” or the “Company”) (NYSE: DQ). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Daqo and certain of its officers and/or directors have engaged in securities fraud or
NEW YORK, March 4, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Calumet Specialty Products Partners, L.P. (“Calumet” or the “Company”) (NASDAQ: CLMT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Calumet and certain of its officers and/or directors have engaged in securities fraud or
NEW YORK, Feb. 15, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Calavo Growers, Inc. (“Calavo” or the “Company”) (NASDAQ: CVGW). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Calavo and certain of its officers and/or directors have engaged in securities fraud or
NEW YORK, Jan. 6, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of BlackRock, Inc. (“BlackRock” or the “Company”) (NYSE: BLK). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether BlackRock and certain of its officers and/or directors have engaged in securities fraud or